Survivor Story
Mary Catherine Riley is living cancer-free thanks to a clinical trial involving two targeted therapeutics for her stage 3 ovarian cancer.
Read Mary Catherine's Story
Mary Catherine Riley is living cancer-free thanks to a clinical trial involving two targeted therapeutics for her stage 3 ovarian cancer.
Read Mary Catherine's Story
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe Philadelphia Cycling Classic is returning. Experience the 14-mile course as part of the AACR Riders for Research team while raising critical funds for cancer science and medicine.
Listen and SubscribeMore than 226,000 people living in the United States were diagnosed with lung cancer last year. Learn about prevention, screening, and treatment options for lung cancer.
Learn MoreBoosting the Immune Response to Cancer: Decades of pioneering research led to a first-of-its-kind FDA approval for a new type of immunotherapy—tumor-infiltrating lymphocyte (TIL) therapy.
Learn MoreUseful information for cancer patients and their families, survivors, caregivers, advocates, and others from Cancer Today magazine.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowAdvance registration is open for the AACR Annual Meeting 2026. Register by February 27 to receive discounted rates.
The AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn MoreThe AACR and its more than 61,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Progress Report 2025 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 61,000 members worldwide drive progress against cancer.
Donate Now
